Shintaro Chiba

Texas Tech University

Papers

2

Total Citations

44

H-Index

2

About

Dr. Shintaro Chiba is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for the treatment of gastrointestinal and hepatobiliary malignancies. His work has been instrumental in demonstrating the safety and efficacy of laparoscopic and robotic approaches for complex tumors, particularly gastrointestinal stromal tumors (GIST). In his highly cited 2022 study, "Trends and outcomes of minimally invasive surgery for gastrointestinal stromal tumors (GIST)," he analyzed national data to show that minimally invasive surgery yields comparable oncologic outcomes with faster recovery and fewer complications than open surgery, a finding that has helped shift clinical practice toward less invasive approaches. Dr. Chiba has also pioneered the integration of frailty assessment into surgical decision-making, as evidenced by his influential work on post-hepatectomy outcomes. His research, which has garnered over 44 citations to date, provides critical evidence for tailoring surgical strategies to individual patient risk profiles. Through these contributions, Dr. Chiba is shaping a future where cancer surgery is both more effective and less burdensome for patients.

Research Focus

Key Achievements

2
H-Index
2
Papers
44
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Trends and outcomes of minimally invasive surgery for gastrointestinal stromal tumors (GIST)
30 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Texas Tech University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago